Coeptis Therapeutics Ownership | Who Owns Coeptis Therapeutics?
Coeptis Therapeutics Ownership Summary
Coeptis Therapeutics is owned by 0.01% institutional investors, 18.51% insiders, and 81.48% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.54% of its assets in Coeptis Therapeutics shares.
COEP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Coeptis Therapeutics | 0.01% | 18.51% | 81.48% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 306.69% | 11.10% | -217.79% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 1 | -92.86% | 2,250 | -99.87% | - | 0.03% | - | -100.00% | 1 | -66.67% |
| Sep 30, 2024 | 14 | -17.65% | 1,706,141 | 1.72% | 4 | 23.34% | 4 | -33.33% | 3 | - |
| Jun 30, 2024 | 17 | -15.00% | 1,677,279 | -64.64% | 4 | 2.87% | 6 | -33.33% | 3 | 50.00% |
| Mar 31, 2024 | 20 | 5.26% | 4,744,007 | 0.24% | 12 | 8.15% | 9 | -35.71% | 2 | - |
| Dec 31, 2023 | 19 | 35.71% | 4,732,850 | 43.81% | 12 | 16.82% | 14 | 100.00% | 2 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 18.91K | 0.54% | -8.62K |
| Fidelity Extended Market Index | 13.30K | 0.28% | 1.59K |
| Fidelity Series Total Market Index | 3.87K | 0.08% | 799.00 |
| Northern Trust Extended Eq Market Idx | 2.53K | 0.07% | - |
| NT Ext Equity Mkt Idx Fd - L | 2.53K | 0.07% | - |
| Fidelity Total Market Index | 3.33K | 0.07% | 2.19K |
| Spartan Extended Market Index Pool F | 2.85K | 0.06% | 110.00 |
| Spartan Total Market Index Pool G | 1.63K | 0.03% | 316.00 |
| Fidelity Nasdaq Composite Index | 1.23K | 0.03% | 936.00 |
| NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 714.00 | 0.02% | 106.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 10, 2024 | Cogley Brian | Chief Financial Officer | Buy | $3.35K |
| Jan 12, 2024 | DeSilva Tara | - | Buy | $260.96 |
| Jan 12, 2024 | DeSilva Tara | - | Buy | $1.04K |
| Jan 05, 2024 | Yerace Daniel Alexander | VP of Operations | Buy | $7.49K |
| Jan 05, 2024 | Salkind Gene | - | Buy | $8.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q1 | 9 | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 4 | - |
| 2023 Q1 | - | - |
COEP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools